Hu, Qianxue
Hao, Yuzhe
Gao, Pei
Long, Ziyi
Huo, Bingyue
Cheng, Xiangning
Xie, Tianjian
Li, Liyue
Zhou, Tao
Zhou, Liuqing
Chen, Shan
Cheng, Qing
Zhou, Yue
Xiao, Hongjun
Chen, Jianjun https://orcid.org/0000-0002-8631-4558
Funding for this research was provided by:
Innovative Research Group Project of the National Natural Science Foundation of China (82371124)
Article History
Received: 5 October 2025
Accepted: 29 December 2025
First Online: 20 January 2026
Declarations
:
: Prior to the initiation of treatment, all patients were fully informed about the purpose, necessity, and potential risks of the study. Written informed consent was obtained from each participant after they voluntarily agreed to take part. Throughout the clinical trial, close communication was maintained between the researchers and the patients.
: This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (approval number: [2022]0221-01).
: The authors declare no conflict of interest.